CD274 and gastric cancer: This retrospective study aims to address this knowledge gap by investigating the efficacy of nivolumab plus chemotherapy in advanced gastric cancer patients stratified by PD-L1 CPS levels, comparing outcomes between those with CPS < 5 and ≥5.